Sb. Lehrer et G. Reese, RECOMBINANT PROTEINS IN NEWLY DEVELOPED FOODS - IDENTIFICATION OF ALLERGENIC ACTIVITY, International archives of allergy and immunology, 113(1-3), 1997, pp. 122-124
A number of agricultural crops are being modified for various purposes
using recombinant DNA technology. Since transferred genes may code fo
r proteins that an ordinarily not present, there is concern about the
potential allergenicity of these new varieties. The safety evaluation
of transgenic foods is relatively easy when the allergenicity of the g
ene source is known. Recombinant allergens in genetically engineered o
r altered foods can be identified using traditional immunological assa
ys such as RAST or ELISA inhibition or immunoblotting procedures, Our
recent studies of two corn proteins (10 kD and HSZ) used to alter grai
n amino acid composition and of transgenic soybeans with an altered fa
tty acid profile are examples of this approach, Both 10 kD and HSZ did
not bind IgE antibodies from sera of corn-reactive subjects by immuno
blotting. Studies of wild-type and transgenic soybeans with high oleic
acidic content by RAST inhibition and immunoblotting with pooled sera
of soy-allergic individuals demonstrated no difference in the allerge
n content of both extracts. In contrast to these studies, a recent inv
estigation by Nordlee et al. (1996) of transgenic soybeans which expre
ssed a methionine/cysteine-rich protein from Brazil nuts identified th
is protein as a major Brazil nut allergen, These studies indicate that
, when the gene source is from a known allergen or if the recipient co
ntains allergens, it is possible to determine whether the allergen con
tent of the transgenic line is altered relative to the nontransgenic v
arieties.